Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical research

Biotechnology and Bioengineering

Volumn 108, Issue 1, 2011, Pages 141-150

  Bierwolf, Jeanette ^a   Lutgehetmann, Marc ^a   Feng, Kai ^b   Erbes, Johannes ^a   Deichmann, Steffen ^a   Toronyi, Eva ^a   Stieglitz, Christina ^a   Nashan, Bjoern ^a   Ma, Peter X ^b   Pollok, Joerg M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Hepatocytes; Nano; Pharmacology; Polymer scaffolds; Tissue engineering; Toxicology

Indexed keywords

HEPATOCYTES; NANO; PHARMACOLOGY; POLYMER SCAFFOLDS; TOXICOLOGY;

LIVER; PHYSIOLOGY; POLYMERASE CHAIN REACTION; POLYMERS; RNA; SCAFFOLDS; THREE DIMENSIONAL; TISSUE; TISSUE ENGINEERING; TOXICITY;

CELL CULTURE;

ALBUMIN; CELL MARKER; CONNEXIN 32; CYTOCHROME; POLYMER; PROTEIN ZO1; RNA;

ANIMAL CELL; ARTICLE; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL REGENERATION; CELL VIABILITY; DRUG RESEARCH; GLYCOGEN STORAGE DISEASE; IMMUNOFLUORESCENCE; LIVER CELL; MICROENVIRONMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TIGHT JUNCTION; TISSUE REGENERATION; TOXICOLOGY;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; HEPATOCYTES; LIVER, ARTIFICIAL; NANOFIBERS; ORGAN CULTURE TECHNIQUES; PHARMACOLOGY; POLYMERS; RATS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOXICOLOGY;

RATTUS;

EID: 78649427926     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22924     Document Type: Article

References (43)

1. Abu-Absi SF, Friend JR, Hansen LK, Hu WS. 2002. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res 274(1): 56-67.
2. Aly HA, Domenech O. 2009. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes. Toxicology 262(3): 175-183.
3. Chen VJ, Ma PX. 2004. Nano-fibrous poly(L-lactic acid) scaffolds with interconnected spherical macropores. Biomaterials 25(11): 2065-2073.
4. Chen VJ, Smith LA, Ma PX. 2006. Bone regeneration on computer-designed nano-fibrous scaffolds. Biomaterials 27(21): 3973-3979.
5. Dean S, Tang JI, Seckl JR, Nyirenda MJ. 2010. Developmental and tissue-specific regulation of hepatocyte nuclear factor 4-alpha (HNF4-alpha) isoforms in rodents. Gene Expr 14(6): 337-344.
6. Donato MT, Castell JV. 2003. Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: Focus on in vitro studies. Clin Pharmacokinet 42(2): 153-178.
7. Dvir-Ginzberg M, Gamlieli-Bonshtein I, Agbaria R, Cohen S. 2003. Liver tissue engineering within alginate scaffolds: Effects of cell-seeding density on hepatocyte viability, morphology, and function. Tissue Eng 9(4): 757-766.
8. Ellis JK, Chan PH, Doktorova T, Athersuch TJ, Cavill R, Vanhaecke T, Rogiers V, Vinken M, Nicholson JK, Ebbels T, Keun HC. 2010. Effect of the histone deacetylase inhibitor trichostatin a on the metabolome of cultured primary hepatocytes. J Proteome Res 9(1): 413-419.
9. Fanning AS, Anderson JM. 2009. Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann N Y Acad Sci 1165: 113-120.
10. Gebhardt R, Hengstler JG, Muller D, Glockner R, Buenning P, Laube B, Schmelzer E, Ullrich M, Utesch D, Hewitt N, et al. 2003. New hepatocyte in vitro systems for drug metabolism: Metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev 35(2-3): 145-213.
11. Hamilton GA, Jolley SL, Gilbert D, Coon DJ, Barros S, LeCluyse EL. 2001. Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell Tissue Res 306(1): 85-99.
12. Hertzberg RP, Pope AJ. 2000. High-throughput screening: New technology for the 21st century. Curr Opin Chem Biol 4(4): 445.
13. Hewitt NJ, Lechon MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, et al. 2007. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39(1): 159-234.
14. Hou DX, Arimura M, Fukuda M, Oka T, Fujii M. 2001. Expression of cell adhesion molecule and albumin genes in primary culture of rat hepatocytes. Cell Biol Int 25(3): 239-244.
15. LeCluyse EL, Alexandre E, Hamilton GA, Viollon-Abadie C, Coon DJ, Jolley S, Richert L. 2005. Isolation and culture of primary human hepatocytes. Methods Mol Biol 290: 207-229.
16. Lee J, Cuddihy MJ, Cater GM, Kotov NA. 2009. Engineering liver tissue spheroids with inverted colloidal crystal scaffolds. Biomaterials 30(27): 4687-4694.
17. Li J, Ning G, Duncan SA. 2000. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14(4): 464-474.
18. Li Y, Qi XM, Xue X, Wu XF, Wu YF, Chen M, Xing GZ, Luan Y, Ren J. 2009. The relationship between diphenylamine structure and NSAIDs-induced hepatocytes injury. Toxicol Lett 186(2): 111-114.
19. Lindros KO, Oinonen T, Issakainen J, Nagy P, Thorgeirsson SS. 1997. Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver. Cell Biol Toxicol 13(4-5): 257-262.
20. Liu X, Won Y, Ma PX. 2006. Porogen-induced surface modification of nano-fibrous poly(L-lactic acid) scaffolds for tissue engineering. Biomaterials 27(21): 3980-3987.
21. Ma PX. 2003. Tissue engineering. Hoboken, NJ: John Wiley and Sons, Inc.
22. Ma PX. 2004. Scaffolds for tissue fabrication. Mater Today 7(5): 30-40.
23. Ma PX. 2008. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60(2): 184.
24. Ma PX, Choi JW. 2001. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng 7(1): 23-33.
25. Ma PX, Zhang R. 1999. Synthetic nano-scale fibrous extracellular matrix. J Biomed Mater Res 46(1): 60-72.
26. Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP, Langer R. 1993. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res 27(2): 183-189.
27. Piechocki MP, Toti RM, Fernstrom MJ, Burk RD, Ruch RJ. 2000. Liver cell-specific transcriptional regulation of connexin 32. Biochim Biophys Acta 1491(1-3): 107-122.
28. Pollok JM. 2003. Engineering of liver tissue within a dynamic flow culture bioreactor for transplantation. University Medical Center Hamburg-Eppendorf.
29. Pollok JM, Kluth D, Cusick RA, Lee H, Utsunomiya H, Ma PX, Langer R, Broelsch CE, Vacanti JP. 1998. Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions. Eur J Pediatr Surg 8(4): 195-199.
30. Provin C, Takano K, Sakai Y, Fujii T, Shirakashi R. 2008. A method for the design of 3D scaffolds for high-density cell attachment and determination of optimum perfusion culture conditions. J Biomech 41(7): 1436-1449.
31. Santos DM, Santos MM, Viana RJ, Castro RE, Moreira R, Rodrigues CM. 2009. Naphtho[2, 3-d]isoxazole-4, 9-dione-3-carboxylates: Potent, non-cytotoxic, antiapoptotic agents. Chem Biol Interact 180(2): 175-182.
32. Schrem H, Klempnauer J, Borlak J. 2002. Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 54(1): 129-158.
33. Shitara Y, Nagamatsu Y, Wada S, Sugiyama Y, Horie T. 2009. Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats. Drug Metab Dispos 37(6): 1172-1178.
34. Smith LA, Ma PX. 2004. Nano-fibrous scaffolds for tissue engineering. Colloids Surf B Biointerfaces 39(3): 125-131.
35. Torok E, Pollok JM, Ma PX, Kaufmann PM, Dandri M, Petersen J, Burda MR, Kluth D, Perner F, Rogiers X. 2001a. Optimization of hepatocyte spheroid formation for hepatic tissue engineering on three-dimensional biodegradable polymer within a flow bioreactor prior to implantation. Cells Tissues Organs 169(1): 34-41.
36. Torok E, Pollok JM, Ma PX, Vogel C, Dandri M, Petersen J, Burda MR, Kaufmann PM, Kluth D, Rogiers X. 2001b. Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor. Dig Surg 18(3): 196-203.
37. Torok E, Pollok JM, Ma PX, Kaufmann PM, Dandri M, Petersen J, Burda MR, Kluth D, Perner F, Rogiers X. 2002. Pre-implantation optimization of culture conditions for hepatocytes in a flow bioreactor for hepatic tissue engineering on 3-dimensional biodegradable polymers. Zentralbl Kinderchir 11: 188-194.
38. Torok E, Vogel C, Lutgehetmann M, Ma PX, Dandri M, Petersen J, Burda MR, Siebert K, Dullmann J, Rogiers X, et al. 2006. Morphological and functional analysis of rat hepatocyte spheroids generated on poly(L-lactic acid) polymer in a pulsatile flow bioreactor. Tissue Eng 12(7): 1881-1890.
39. Tuschl G, Mueller SO. 2006. Effects of cell culture conditions on primary rat hepatocytes-Cell morphology and differential gene expression. Toxicology 218(2-3): 205-215.
40. Wei G, Ma PX. 2006. Macroporous and nanofibrous polymer scaffolds and polymer/bone-like apatite composite scaffolds generated by sugar spheres. J Biomed Mater Res A 78(2): 306-315.
41. Woo KM, Chen VJ, Ma PX. 2003. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A 67A (2): 531-537.
42. Woo KM, Jun JH, Chen VJ, Seo J, Baek JH, Ryoo HM, Kim GS, Somerman MJ, Ma PX. 2007. Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials 28(2): 335-343.
43. Yang TH, Miyoshi H, Ohshima N. 2001. Novel cell immobilization method utilizing centrifugal force to achieve high-density hepatocyte culture in porous scaffold. J Biomed Mater Res 55(3): 379-386.